Page 47 - Platelets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Samaritan rescued the girl and she was flown here, broken and battered. left leg shattered. skull fractured. a small collection of blood on her brain, but, yes, very much alive. such an incredible story, anderson, i mean, just think about that building that you saw there. she was asleep in a cot next to that window. had she been in that cot, still in that cot she would have most likely died just by what had happened to that building. instead she was thrown out of the building and survived. as you saw there. >> that's incredible. >> reporter: i just saw her, she's doing well. >> unbelievable. y...

© Provided by Xinhua TIANJIN, Feb. 6 (Xinhua) -- After finishing a physical examination and giving a blood sample, Peter Mecoy deftly rolled up his sle

Despite evidence that starting two blood-thinning medications shortly after a minor stroke or a warning stroke (transient ischemic attack - TIA) may prevent a second – possibly more serious – clot-caused stroke within a few months, the treatment regimen is underused especially among women, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

This drug is the first BTK inhibitor approved to treat mantle cell lymphoma in this setting. Approval was based on overall response rates and duration of response in the phase 1/2 BRUIN trial.

The FDA granted accelerated approval to the BTK inhibitor zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.